Tag Archives: Postmarket Study

Essure Postmarket Study to be conducted in Wake of Reported Injuries

After thousands of problems associated with permanent contraceptive device Essure were reported to the FDA, the device regulator ordered the device’s manufacturer Bayer to submit plans for a postmarket surveillance study. The FDA requires these kinds of studies for devices that have posed significant adverse health problems or are permanent implants.Read more

Real Time Analytics